# OnCo record pegvisomant (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/pegvisomant/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "pegvisomant" ;
  schema:name "Pegvisomant"@en ;
  schema:alternateName "B2036-PEG"@en, "Somavert" ;
  schema:description "Pegvisomant is a daily injection that blocks growth hormone at its receptor. It normalises the downstream hormone IGF-1 in most people with acromegaly whose tumours were not cured by surgery, although it does not shrink the tumour itself."@en ;
  schema:url <https://onco.cc/drugs/pegvisomant/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Pegvisomant> ;
  schema:citation <https://en.wikipedia.org/wiki/Pegvisomant> ;
  onco:status "approved" ;
  onco:tag "subtype-drugs-wave" ;
  onco:modality "Pegylated growth hormone receptor antagonist (daily subcutaneous injection)" ;
  onco:approval "US 2003: Acromegaly with inadequate response to surgery or radiotherapy and other medical therapies" ;
  onco:related <https://onco.cc/drugs/pasireotide/>, <https://onco.cc/drugs/octreotide-lanreotide/> ;
  onco:cancers <https://onco.cc/cancers/pituitary-tumours/> ;
  onco:companies <https://onco.cc/companies/pfizer/> .